Cardiff Oncology Ownership | Who Owns Cardiff Oncology?

Overview RevenueFinancials Chart Transcripts

Cardiff Oncology Ownership Summary

Cardiff Oncology is owned by 26.69% institutional investors, 6.60% insiders, and 66.71% retail investors. Blackrock is the largest institutional shareholder, holding 5.88% of CRDF shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.03% of its assets in Cardiff Oncology shares.

CRDF Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cardiff Oncology	26.69%	6.60%	66.71%
Sector	Healthcare Stocks	88.01%	8.90%	3.09%
Industry	Biotech Stocks	109.70%	8.77%	-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	2.63M	5.88%	$5.84M
Vanguard group	2.14M	4.78%	$4.74M
Geode capital management	910.67K	2.04%	$2.02M
State street	805.02K	1.80%	$1.79M
Mai capital management	658.79K	1.47%	$1.46M
Morgan stanley	513.22K	1.15%	$1.14M
Marshall wace, llp	298.83K	0.67%	$663.40K
Millennium management	239.61K	0.54%	$531.93K
Blair william & co/il	227.63K	0.51%	$505.34K
Two sigma investments, lp	218.63K	0.49%	$485.36K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Elkhorn partners limited partnership	41.00K	0.06%	$91.00K
Avestar capital	140.47K	0.05%	$609.63K
Denver wealth management	15.23K	0.03%	$66.12K
Findec wealth services	16.00K	0.02%	$35.52K
Xtx topco	83.44K	0.02%	$185.23K
Mai capital management	658.79K	0.01%	$1.46M
Baker ellis asset management	20.00K	0.01%	$86.80K
Callan capital	65.05K	0.01%	$144.40K
Invst	36.00K	0.01%	$73.80K
Thoroughbred financial services	52.38K	0.01%	$116.00K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	2.63M	0.00%	1.95M
State street	805.02K	0.00%	665.08K
Geode capital management	910.67K	0.00%	475.84K
Morgan stanley	513.22K	0.00%	433.80K
Vanguard group	2.14M	0.00%	215.08K

Top Sellers

Holder	Shares	% Assets	Change
Laurion capital management lp	-	-	-928.72K
Millennium management	239.61K	0.00%	-443.69K
Assenagon asset management	67.23K	0.00%	-203.29K
Eam investors	-	-	-161.90K
Ubs oconnor	-	-	-150.00K

New Positions

Holder	Shares	% Assets	Change	Value
Nuveen asset management	53.12K	-	53.12K	$117.92K
Thoroughbred financial services	52.38K	0.01%	52.38K	$116.00K
New york state common retirement fund	43.00K	0.00%	43.00K	$95.00K
Cetera investment advisers	40.50K	0.00%	40.50K	$89.91K
Invst	36.00K	0.01%	36.00K	$73.80K

Sold Out

Holder	Change
Front row advisors	-2.00
Newbridge financial services group	-17.00
Macquarie group	-1.37K
America first investment advisors	-4.00K
Connor, clark & lunn investment management	-10.11K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	88	-8.33%	12,508,364	-2.23%	26	3.25%	34	-45.16%	23	109.09%
Jun 30, 2024	96	17.07%	12,794,219	52.97%	28	8.17%	62	40.91%	11	-
Mar 31, 2024	82	41.38%	8,363,780	57.97%	18	13.33%	44	214.29%	11	-21.43%
Dec 31, 2023	58	-3.33%	5,294,425	-2.97%	11	7.95%	14	-26.32%	14	-
Sep 30, 2023	60	13.21%	5,456,266	-8.95%	12	6.79%	19	11.76%	14	75.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.35M	2.03%	95.37K
iShares Russell 2000 ETF	1.08M	1.62%	-4.13K
Vanguard Institutional Extnd Mkt Idx Tr	600.17K	0.90%	-
CREF Stock R1	467.38K	0.70%	467.38K
Fidelity Small Cap Index	399.87K	0.60%	-286.00
BIT Biotech Opportunities S	253.09K	0.49%	-42.43K
Fidelity Extended Market Index	243.07K	0.37%	-1.60K
iShares Russell 2000 Value ETF	233.66K	0.35%	-6.55K
State St Russell Sm/Mid Cp® Indx NL Cl C	225.25K	0.34%	-4.30K
Vanguard Russell 2000 ETF	195.81K	0.29%	12.18K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 16, 2024	Levine James E.	Chief Financial Officer	Buy	$9.82K
Dec 17, 2024	Levine James E.	Chief Financial Officer	Buy	$14.91K
Dec 18, 2024	Levine James E.	Chief Financial Officer	Buy	$12.00K
Dec 12, 2024	TANNENBAUM RENEE P	-	Buy	$34.22K
Dec 11, 2024	PACE GARY W	-	Buy	$29.90K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	6	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	2	-
2023 Q2	-	-

CRDF Ownership FAQ

Who Owns Cardiff Oncology?

Cardiff Oncology shareholders are primarily institutional investors at 26.69%, followed by 6.60% insiders and 66.71% retail investors. The average institutional ownership in Cardiff Oncology's industry, Biotech Stocks , is 109.70%, which Cardiff Oncology falls below.

Who owns the most shares of Cardiff Oncology?

Cardiff Oncology’s largest shareholders are Blackrock (2.63M shares, 5.88%), Vanguard group (2.14M shares, 4.78%), and Geode capital management (910.68K shares, 2.04%). Together, they hold 12.70% of Cardiff Oncology’s total shares outstanding.

Does Blackrock own Cardiff Oncology?

Yes, BlackRock owns 5.88% of Cardiff Oncology, totaling 2.63M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 5.84M$. In the last quarter, BlackRock increased its holdings by 1.95M shares, a 287.98% change.

Who is Cardiff Oncology’s biggest shareholder by percentage of total assets invested?

Elkhorn partners limited partnership is Cardiff Oncology’s biggest shareholder by percentage of total assets invested, with 0.06% of its assets in 41K Cardiff Oncology shares, valued at 91K$.

Who is the top mutual fund holder of Cardiff Oncology shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cardiff Oncology shares, with 2.03% of its total shares outstanding invested in 1.35M Cardiff Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools